BidaskClub lowered shares of Viewray (NASDAQ:VRAY) from a hold rating to a sell rating in a research report report published on Wednesday morning.

VRAY has been the topic of a number of other reports. ValuEngine cut Viewray from a hold rating to a sell rating in a research note on Friday, December 1st. Mizuho restated a buy rating and issued a $12.00 price objective on shares of Viewray in a research note on Monday, November 13th. B. Riley assumed coverage on Viewray in a research note on Thursday, February 8th. They issued a buy rating and a $13.50 price objective on the stock. Northland Securities restated a buy rating and issued a $10.00 price objective on shares of Viewray in a research note on Friday, November 17th. Finally, Cantor Fitzgerald set a $13.00 price objective on Viewray and gave the company a buy rating in a research note on Monday, January 8th. Two research analysts have rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $11.58.

Viewray (NASDAQ VRAY) traded up $0.42 during midday trading on Wednesday, hitting $8.17. The stock had a trading volume of 578,200 shares, compared to its average volume of 712,467. Viewray has a 12 month low of $4.40 and a 12 month high of $10.64. The company has a current ratio of 1.59, a quick ratio of 1.20 and a debt-to-equity ratio of -1.67.

Viewray (NASDAQ:VRAY) last announced its quarterly earnings data on Monday, November 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.07). The company had revenue of $12.20 million during the quarter, compared to analyst estimates of $18.63 million. The company’s revenue was up 2950.0% compared to the same quarter last year. sell-side analysts forecast that Viewray will post -1.05 EPS for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the stock. Park West Asset Management LLC purchased a new position in Viewray during the 4th quarter valued at about $24,217,000. PEAK6 Investments L.P. purchased a new position in Viewray during the 4th quarter valued at about $148,000. Perceptive Advisors LLC purchased a new position in Viewray during the 4th quarter valued at about $463,000. Deutsche Bank AG grew its holdings in Viewray by 137.6% during the 4th quarter. Deutsche Bank AG now owns 67,190 shares of the company’s stock valued at $622,000 after buying an additional 38,913 shares in the last quarter. Finally, RTW Investments LP grew its holdings in Viewray by 32.1% during the 4th quarter. RTW Investments LP now owns 1,348,210 shares of the company’s stock valued at $12,484,000 after buying an additional 327,748 shares in the last quarter. Institutional investors and hedge funds own 50.61% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Viewray (VRAY) Rating Lowered to Sell at BidaskClub” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2018/02/15/viewray-vray-rating-lowered-to-sell-at-bidaskclub.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Analyst Recommendations for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.